Sun Pharma Advanced Research Company is currently trading at Rs. 155.10, up by 12.50 points or 8.77% from its previous closing of Rs. 142.60 on the BSE.
The scrip opened at Rs. 151.40 and has touched a high and low of Rs. 159.90 and Rs. 148.75 respectively. So far 352331 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 300.00 on 09-Nov-2018 and a 52 week low of Rs. 107.00 on 09-Jul-2019.
Last one week high and low of the scrip stood at Rs. 159.90 and Rs. 135.50 respectively. The current market cap of the company is Rs. 4140.35 crore.
The promoters holding in the company stood at 68.46%, while Institutions and Non-Institutions held 4.27%, and 27.26% respectively.
Sun Pharma Advanced Research Company (SPARC) has entered into exclusive licenses with a subsidiary of China Medical System Holdings (CMS) to develop and commercialize multiple products in Mainland China, Hong Kong, Macao and Taiwan.
The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and may be further extended as per mutual agreement between the parties.
SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.
